2010 Proteoglycans Gordon Conference
2010年蛋白多糖戈登会议
基本信息
- 批准号:7902729
- 负责人:
- 金额:$ 3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcademyAddressAreaArthritisAsiaAttentionAustraliaCardiacCartilageCollaborationsDevelopmentDiseaseDrug FormulationsEuropeFoundationsGoalsHereditary Multiple ExostosesHuman DevelopmentImmunityImmunologyInflammationInternationalLeadMalignant NeoplasmsMuscleMusculoskeletal SystemMusculoskeletal System PartNervous system structureOutcomePathologyPharmaceutical PreparationsProteoglycanPublic HealthRare DiseasesRegenerative MedicineRequest for ProposalsResearchResearch PersonnelRoleScientistSkeletonSouth AmericanSystemTechnologyTendon structureTimeTissue EngineeringTooth structureUnderrepresented MinorityVascular SystemVascularizationWomanWorkbiological systemsbonecombathuman diseaseinsightpostersprogramsstem cell biologysymposium
项目摘要
DESCRIPTION (provided by applicant): The proposal requests partial support for the Gordon Research Conference on Proteoglycans that will be held on July 11-16, 2010 in Proctor Academy, Andover, NH. The conference has been held every two years since 1984 and has an outstanding reputation. It brings together a diverse group of investigators who will present new and unpublished high impact research on proteoglycans in an intense yet informal setting. The conference will be composed of invited speakers chosen by a scientific organizing committee that includes former Proteoglycan Gordon Conference Chairs and others who have substantial research expertise proteoglycans research. In addition to assembling high level proteoglycan research scientists the conference provides a forum for new investigators to present their work in poster sessions or, in some cases, as invited speakers to give short talks that are intertwined between the core set of invited speakers. The Gordon conference setting provides a unique and effective way for all of the attendees to closely interact. The extended discussions as well as the well-organized pastoral setting at Proctor Academy gives attendees ample opportunity for direct interaction with speakers so they can gain additional insight into the latest research findings and, at the same, facilitate the formation of new collaborations. The proteoglycan field is well-known for its collegiality, open discussions, and support of junior investigators. Originally the conference focused primarily on cartilage and arthritis. However over time it became clear that proteoglycans have critical functions in numerous biological systems including the formation and pathology of many parts of the musculoskeletal system such as muscle, bone, tendons and teeth. In addition to their function in the skeleton the proteoglycans have fundamental roles in immunology and inflammation, vascularization, cardiac function, cancer and development. The roles of proteoglycans in these systems has provided a pivitol foundation for devising therapy to treat common diseases associated with them and these research areas will be the focus of the proposed conference. Proteoglycans have also been shown to have key roles in rare diseases such as multiple hereditary exostoses, and mucopolysaccaridosis both of which will highlighted in the program. This year two new sessions will be added that will address the role of proteoglycans in stem cell biology and tissue engineering and regenerative medicine (TERM). The Proteoglycan conference is very international with over 40% of the attendees coming from Europe, Asia, South American and Australia. Attendees will be selected by invitation from the applications submitted on- line and will be chosen to represent a diverse set of researchers and careful attention will be paid to the inclusion of women and underrepresented minorities in all aspects of the conference including Discussion Leaders, Speakers, Poster Presenters and Attendees.
描述(由申请人提供):该提案要求对将于2010年7月11日至16日在新罕布什尔州安多弗市普罗克特学院举行的戈登蛋白聚糖研究会议提供部分支持。大会自1984年起每两年举办一次,享有盛誉。它汇集了一群不同的研究人员,他们将在一个紧张而非正式的环境中展示关于蛋白聚糖的新的和未发表的高影响力研究。会议将由科学组织委员会选出的特邀演讲者组成,该委员会包括前蛋白聚糖戈登会议主席和其他具有大量蛋白聚糖研究专业知识的人。除了聚集高水平的蛋白聚糖研究科学家外,会议还为新的研究人员提供了一个论坛,让他们在海报会议上展示自己的工作,或者在某些情况下,作为受邀演讲者进行简短的演讲,这些演讲与核心受邀演讲者之间相互交织。戈登会议设置为所有与会者提供了一个独特而有效的方式来密切互动。延长的讨论以及普罗克特学院组织良好的田园环境为与会者提供了与演讲者直接互动的充分机会,因此他们可以获得对最新研究成果的更多见解,同时促进新合作的形成。蛋白聚糖领域以其合议、公开讨论和对初级研究人员的支持而闻名。最初会议主要集中在软骨和关节炎。然而,随着时间的推移,蛋白聚糖在许多生物系统中具有关键功能,包括肌肉骨骼系统的许多部分如肌肉,骨骼,肌腱和牙齿的形成和病理学。除了在骨骼中的功能外,蛋白聚糖还在免疫学和炎症、血管形成、心脏功能、癌症和发育中发挥重要作用。蛋白聚糖在这些系统中的作用为设计治疗与它们相关的常见疾病的疗法提供了pivitol基础,这些研究领域将成为拟议会议的重点。蛋白聚糖也被证明在罕见疾病中起关键作用,如多发性遗传性外生骨疣和粘多糖病,这两种疾病都将在该计划中强调。今年将增加两个新的会议,将解决蛋白聚糖在干细胞生物学和组织工程和再生医学(TERM)的作用。蛋白聚糖会议是非常国际化的,超过40%的与会者来自欧洲,亚洲,南美和澳大利亚。与会者将通过邀请从在线提交的申请中选出,并将被选择代表不同的研究人员,并将在会议的各个方面,包括讨论领导人,演讲者,海报展示者和与会者,认真关注妇女和代表不足的少数民族的参与。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT J LINHARDT其他文献
ROBERT J LINHARDT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT J LINHARDT', 18)}}的其他基金
Heparan Sulfate 3-O-Sulfation in Transcellular Propagation of Tauopathy in Alzheimer's Disease
硫酸乙酰肝素 3-O-硫酸化在阿尔茨海默氏病 Tau 蛋白病跨细胞传播中的作用
- 批准号:
10054740 - 财政年份:2020
- 资助金额:
$ 3万 - 项目类别:
Characterization of Anticoagulant Heparin and Related Polysaccharides
抗凝肝素及相关多糖的表征
- 批准号:
7939713 - 财政年份:2009
- 资助金额:
$ 3万 - 项目类别:
Characterization of Anticoagulant Heparin and Related Polysaccharides
抗凝肝素及相关多糖的表征
- 批准号:
7853484 - 财政年份:2009
- 资助金额:
$ 3万 - 项目类别:
Stable Carbohydrate Libraries in Infectious Disease
传染病中的稳定碳水化合物库
- 批准号:
7748958 - 财政年份:2007
- 资助金额:
$ 3万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 3万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 3万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 3万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 3万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 3万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 3万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 3万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 3万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 3万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 3万 - 项目类别:
Research Grant














{{item.name}}会员




